Russell Lewis
Citado por
Citado por
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group …
OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ...
The Lancet infectious diseases 19 (12), e405-e421, 2019
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ...
Clinical Microbiology and Infection 24, e1-e38, 2018
Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis
G Chamilos, RE Lewis, DP Kontoyiannis
Clinical Infectious Diseases 47 (4), 503-509, 2008
Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases
DP Kontoyiannis, MS Lionakis, RE Lewis, G Chamilos, M Healy, ...
The Journal of infectious diseases 191 (8), 1350-1360, 2005
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)
G Chamilos, M Luna, RE Lewis, GP Bodey, R Chemaly, JJ Tarrand, ...
haematologica 91 (7), 986-989, 2006
Antifungal drug resistance of pathogenic fungi
DP Kontoyiannis, RE Lewis
The Lancet 359 (9312), 1135-1144, 2002
Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study
M Bartoletti, R Pascale, M Cricca, M Rinaldi, A Maccaro, L Bussini, ...
Clinical Infectious Diseases 73 (11), e3606-e3614, 2021
Current concepts in antifungal pharmacology
RE Lewis
Mayo Clinic Proceedings 86 (8), 805-817, 2011
Mucormycosis caused by unusual mucormycetes, non-Rhizopus,-Mucor, and-Lichtheimia species
MZR Gomes, RE Lewis, DP Kontoyiannis
Clinical Microbiology Reviews 24 (2), 411-445, 2011
Pharmacology of systemic antifungal agents
ESD Ashley, R Lewis, JS Lewis, C Martin, D Andes
Clinical infectious diseases 43 (Supplement_1), S28-S39, 2006
How I treat mucormycosis
DP Kontoyiannis, RE Lewis
Blood, The Journal of the American Society of Hematology 118 (5), 1216-1224, 2011
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
G Chamilos, EM Marom, RE Lewis, MS Lionakis, DP Kontoyiannis
Clinical Infectious Diseases 41 (1), 60-66, 2005
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study
N Singh, AP Limaye, G Forrest, N Safdar, P Munoz, K Pursell, S Houston, ...
Transplantation 81 (3), 320-326, 2006
Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods
ME Klepser, EJ Ernst, RE Lewis, ME Ernst, MA Pfaller
Antimicrobial agents and chemotherapy 42 (5), 1207-1212, 1998
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic …
DP Kontoyiannis, R Hachem, RE Lewis, GA Rivero, HA Torres, J Thornby, ...
Cancer 98 (2), 292-299, 2003
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
PE Verweij, BJA Rijnders, RJM Brüggemann, E Azoulay, M Bassetti, ...
Intensive care medicine 46 (8), 1524-1535, 2020
Canal irrigation and local social organization [and comments and reply]
RC Hunt, E Hunt, GM Ahmed, JW Bennett, RK Cleek, PEB Coy, TF Glick, ...
Current anthropology 17 (3), 389-411, 1976
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007) Stable incidence but changing epidemiology of a still frequently lethal …
NV Sipsas, RE Lewis, J Tarrand, R Hachem, KV Rolston, II Raad, ...
Cancer 115 (20), 4745-4752, 2009
Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management
DP Kontoyiannis, RE Lewis
Infectious Disease Clinics 20 (3), 581-607, 2006
Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes
M Stanzani, E Orciuolo, R Lewis, DP Kontoyiannis, SLR Martins, ...
Blood 105 (6), 2258-2265, 2005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20